Protocol Deviations & Non-Compliance

Linking Risk Categories to Reconsent, Data Handling and Analysis Rules Linking Risk Categories to Reconsent, Data Handling and Analysis Rules In the dynamic landscape of clinical trials, the need for rigorous protocols and regulatory compliance is paramount. Understanding the implications of risk categorization in relation to reconsent processes, data handling, and analysis is critical for…

Read More “Linking Risk Categories to Reconsent, Data Handling and Analysis Rules” »

Risk Categorization Approaches for DCT, Remote Visits and Home Health In the evolving landscape of clinical research, especially amidst the COVID-19 pandemic, the shift towards decentralized clinical trials (DCT), remote visits, and home health innovations has accelerated significantly. This evolution necessitates a structured approach to risk categorization and impact assessment. This article provides a comprehensive…

Read More “Risk Categorization Approaches for DCT, Remote Visits and Home Health” »

Tools and Templates for Consistent Deviation Risk Scoring Tools and Templates for Consistent Deviation Risk Scoring Introduction to Deviation Risk Scoring in Clinical Trials Clinical trials play a critical role in the advancement of medical science and regulatory compliance, necessitating that every aspect of these trials is meticulously monitored and documented. One essential element of…

Read More “Tools and Templates for Consistent Deviation Risk Scoring” »

Regulatory Expectations for Risk-Based Deviation Management Regulatory Expectations for Risk-Based Deviation Management In the complex landscape of clinical trials, managing protocol deviations is paramount to ensure compliance with regulatory frameworks established by bodies such as the FDA, EMA, and MHRA. Understanding how to effectively navigate these deviations—particularly in the context of clinical trial logistics—is crucial…

Read More “Regulatory Expectations for Risk-Based Deviation Management” »

Integrating Impact Assessments With CAPA and Quality Management Systems Integrating Impact Assessments With CAPA and Quality Management Systems In the realm of clinical research, especially in the context of astellas clinical trials, ensuring compliance and quality management is paramount for success. This comprehensive guide will outline the integration of impact assessments with Corrective and Preventive…

Read More “Integrating Impact Assessments With CAPA and Quality Management Systems” »

Training CRAs and Data Managers on Impact Assessment Criteria Training CRAs and Data Managers on Impact Assessment Criteria In the realm of clinical research, ensuring compliance while maintaining participant safety and data integrity is paramount. Protocol deviations and non-compliance can have significant implications on the overall success of a clinical trial. This guide serves as…

Read More “Training CRAs and Data Managers on Impact Assessment Criteria” »

Common Mistakes in Deviation Risk Categorization and How to Avoid Them In the regulated landscape of clinical trials, the categorization of protocol deviations is a critical task that requires precision and adherence to guidelines set forth by regulatory authorities. Mistakes in deviation risk categorization can lead to non-compliance ramifications that affect study integrity and participant…

Read More “Common Mistakes in Deviation Risk Categorization and How to Avoid Them” »